AstraZeneca | Investor Event Presentation Deck | 52 slides · page 22 of 52
The slide outlines a clinical trial structure with six cohorts testing different combinations of Dato-DXd, pembrolizumab, and platinum-based chemotherapy.
Conference presentation · appendix_methodology · present_framework · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 list 1/1 source-note 1/1 table 1/1 title 2/2
Components 6
primary bullet source-note data headline subtitle
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.